跳至主要内容
临床试验/IRCT20180430039488N1
IRCT20180430039488N1招募中3 期

Evaluation of the efficacy of high dose corticosteroid regimen for treatment of postoperative high degree Atrioventricular block after valvular cardiac surgery ; A single blind randomized clinical trial

Tehran Heart Center0 个研究点目标入组 150 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
15 years 至 80 years(—)
性别
All

入选标准

  • Presence of advanced atrioventricular block following heart valve surgery including valve replacement or repair with or without CABG
  • Written documented informed consent

排除标准

  • Exclusion of patients having cardiac pacemakers or intracardiac defibrilator-cardiovertor or CRT
  • Exclusion of subjects having prior advanced AV block with underlying congenital or acquired etiologies or known brady-arrhythmia
  • Exclusion of patients with acute or recent myocardial infarction or CPR during last week (or survivors of aborted sudden cardiac death)
  • Exclusion of diabetics with uncontrolled hyperglycemia ( BS>200 in 2 or more measurements out of 4 samples during last 24 hours or HbA1C>9, ketoacidosis or hyperglycemic hyperosmolar state)
  • Exclusion of patients with active infections
  • Exclusion of patients with immune deficiency disorders including malignancies and HIV-AIDS,....
  • Exclusion of patients with prior history of hypersensitivity reactions to steroids
  • Exclusion of patients with persistent or permanent atrial fibrillation (AF for more than 24 hours except transient or paroxysmal cases)

研究者

发起方
Tehran Heart Center

相似试验